[Asymmetrical methylarginine (ADMA) as a cardiovascular risk factor: epidemiological and prospective data].

Böger, R H

[Asymmetrical methylarginine (ADMA) as a cardiovascular risk factor: epidemiological and prospective data]. [electronic resource] - Deutsche medizinische Wochenschrift (1946) Apr 2004 - 820-4 p. digital

Publication Type: Comparative Study; Journal Article; Review

0012-0472

10.1055/s-2004-822880 doi


Adult
Aged
Aged, 80 and over
Animals
Arginine--analogs & derivatives
Arteriosclerosis--blood
Biomarkers
Cardiovascular Diseases--blood
Case-Control Studies
Cells, Cultured
Child
Coronary Disease--blood
Diabetes Mellitus, Type 2--blood
Disease Models, Animal
Endothelial Cells--drug effects
Enzyme-Linked Immunosorbent Assay
Female
Free Radicals
Humans
Hypertension--blood
Kidney Failure, Chronic--blood
Male
Middle Aged
Multicenter Studies as Topic
Multivariate Analysis
Nitric Oxide Synthase--antagonists & inhibitors
Oxidative Stress
Pre-Eclampsia--blood
Pregnancy
Prospective Studies
Rabbits
Regression Analysis
Renal Dialysis
Risk Factors
Stroke--blood